Corbus Pharmaceuticals announces positive results from its CRB-913 obesity treatment trial, highlighting significant weight loss and favorable safety profile.
| Name | Corbus Pharmaceuticals Holdings, Inc. |
|---|---|
| CIK | 0001595097 |
| Tickers | CRBP |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 464348039 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 617-963-0103 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Corbus Pharmaceuticals announces positive results from its CRB-913 obesity treatment trial, highlighting significant weight loss and favorable safety profile.
Corbus Pharmaceuticals Holdings, Inc. announces its Q3 2026 financial results, detailing operational metrics and future outlook in the pharmaceutical sector.
Corbus Pharmaceuticals updates its business presentation, enhancing transparency and communication with investors, reflecting industry trends in pharmaceutical preparations.
812 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-26-462186 | 001-37348 | 261555586 | 34 | 24488419 | 1 | 1 |
| 2026-11-13 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001687078-26-000022 | 005-88716 | 261550534 | 34 | 6956 | |||
| 2026-11-10 | 10-Q | 10-Q | 0001193125-26-455614 | 001-37348 | 261541036 | 34 | 9289151 | 1 | 1 | |
| 2026-11-10 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-26-454476 | 001-37348 | 261538056 | 34 | 439536 | 1 | 1 |
| 2026-11-02 | 4 | xslF345X06/form4.xml | 0000929638-26-004182 | 9680 | ||||||
| 2026-11-02 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000929638-26-004181 | 005-88716 | 261512281 | 34 | 9041 | |||
| 2026-10-29 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001716774-26-000025 | 005-88716 | 261498569 | 34 | 8973 | |||
| 2026-10-15 | 8-K | 8-K | 7.01,9.01 | 0001193125-26-422437 | 001-37348 | 261461834 | 34 | 26268105 | 1 | 1 |
| 2026-09-30 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001346824-26-000243 | 005-88716 | 261427780 | 34 | 18905 | |||
| 2026-09-15 | 4 | 4 | 0001193125-26-392093 | 5547 | ||||||
| 2026-09-14 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-26-389829 | 001-37348 | 261375788 | 34 | 25178230 | 1 | 1 |
| 2026-08-17 | 4 | 4 | 0001193125-26-354145 | 8351 | ||||||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-097066 | 005-88716 | 261281006 | 34 | 17983 | |||
| 2026-08-12 | 4 | 4 | 0001193125-26-346966 | 4856 | ||||||
| 2026-08-10 | 4 | 4 | 0001193125-26-342485 | 5569 | ||||||
| 2026-08-10 | 4 | 4 | 0001193125-26-342479 | 5571 | ||||||
| 2026-08-07 | 424B5 | 424B5 | 0001193125-26-340378 | 333-277888 | 261254835 | 33 | 735502 | |||
| 2026-08-07 | 144 | xsl144X01/primary_doc.xml | 0001972481-26-000255 | 001-37348 | 261254369 | 33 | 5133 | |||
| 2026-08-07 | 144 | xsl144X01/primary_doc.xml | 0001972481-26-000254 | 001-37348 | 261253889 | 33 | 5114 | |||
| 2026-08-06 | 10-Q | 10-Q | 0001193125-26-338274 | 001-37348 | 261249824 | 34 | 10212115 | 1 | 1 | |
| 2026-08-06 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-26-336864 | 001-37348 | 261246194 | 34 | 432157 | 1 | 1 |
| 2026-08-04 | 3 | 3 | 0001193125-26-332936 | 13907 | ||||||
| 2026-07-27 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002012383-26-002244 | 005-88716 | 261206129 | 34 | 10889 | |||
| 2026-07-27 | 144 | xsl144X01/primary_doc.xml | 0001972481-26-000237 | 001-37348 | 261205798 | 33 | 6623 | |||
| 2026-07-06 | 8-K | 8-K | 1.01,7.01,9.01 | 0001193125-26-295622 | 001-37348 | 261154332 | 34 | 482299 | 1 | 1 |
| 2026-06-17 | S-8 | S-8 | 0001193125-26-274226 | 333-296858 | 261098950 | 33 | 742535 | 1 | 1 | |
| 2026-06-11 | 4 | 4 | 0001193125-26-267672 | 5531 | ||||||
| 2026-06-11 | 4 | 4 | 0001193125-26-267655 | 5487 | ||||||
| 2026-06-11 | 4 | 4 | 0001193125-26-267671 | 5554 | ||||||
| 2026-06-03 | 4 | 4 | 0001193125-26-255834 | 6809 | ||||||
| 2026-05-29 | S-8 | S-8 | 0001193125-26-248550 | 333-296370 | 261045582 | 33 | 337014 | 1 | 1 | |
| 2026-05-26 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-26-238059 | 001-37348 | 261016074 | 34 | 23570350 | 1 | 1 |
| 2026-05-22 | 4 | 4 | 0001193125-26-237103 | 8272 | ||||||
| 2026-05-22 | 3 | 3 | 0001193125-26-237096 | 15086 | ||||||
| 2026-05-21 | 4 | 4 | 0001193125-26-234860 | 7402 | ||||||
| 2026-05-21 | 4 | 4 | 0001193125-26-234857 | 7438 | ||||||
| 2026-05-21 | 4 | 4 | 0001193125-26-234853 | 7425 | ||||||
| 2026-05-21 | 4 | 4 | 0001193125-26-234851 | 7358 | ||||||
| 2026-05-21 | 4 | 4 | 0001193125-26-234850 | 7419 | ||||||
| 2026-05-21 | 4 | 4 | 0001193125-26-234813 | 7834 | ||||||
| 2026-05-21 | 3 | 3 | 0001193125-26-234777 | 14695 | ||||||
| 2026-05-21 | 8-K | 8-K | 1.01,5.02,7.01,9.01 | 0001193125-26-233507 | 001-37348 | 261005945 | 34 | 494571 | 1 | 1 |
| 2026-05-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001214659-26-006202 | 005-88716 | 26978576 | 34 | 10969 | |||
| 2026-05-14 | 8-K | 8-K | 5.02,5.07,7.01,9.01 | 0001193125-26-222890 | 001-37348 | 26975966 | 34 | 270349 | 1 | 1 |
| 2026-05-12 | 10-Q | 10-Q | 0001193125-26-219707 | 001-37348 | 26969519 | 34 | 8140224 | 1 | 1 | |
| 2026-05-12 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-26-218250 | 001-37348 | 26965981 | 34 | 368096 | 1 | 1 |
| 2026-04-16 | DEFA14A | DEFA14A | 0001193125-26-159074 | 001-37348 | 26867872 | 34 | 29154 | |||
| 2026-04-16 | 8-K | 8-K | 5.02,9.01 | 0001193125-26-159062 | 001-37348 | 26867842 | 34 | 743555 | 1 | 1 |
| 2026-04-14 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-26-153923 | 001-37348 | 26859233 | 34 | 193502 | 1 | 1 |
| 2026-04-07 | 8-K | 8-K | 5.02,7.01,8.01,9.01 | 0001193125-26-144588 | 001-37348 | 26842986 | 34 | 199829 | 1 | 1 |
| 2026-04-02 | ARS | ARS | 0001193125-26-140398 | 001-37348 | 26834859 | 34 | 5686139 | |||
| 2026-04-02 | DEFA14A | DEFA14A | 0001193125-26-140385 | 001-37348 | 26834808 | 34 | 2601904 | |||
| 2026-04-02 | DEF 14A | DEF 14A | 0001193125-26-140363 | 001-37348 | 26834719 | 34 | 5997997 | 1 | 1 | |
| 2026-03-25 | 424B3 | 424B3 | 0001193125-26-124201 | 333-294217 | 26792884 | 33 | 488258 | |||
| 2026-03-20 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-000891 | 333-294217 | 26779753 | 33 | 1834 | ||
| 2026-03-18 | CORRESP | filename1.htm | 0001193125-26-113993 | 19638 | ||||||
| 2026-03-13 | UPLOAD | filename1.pdf | 0000000000-26-002620 | 333-294217 | 40171 | |||||
| 2026-03-11 | S-3 | S-3 | 0001193125-26-102396 | 333-294217 | 26744354 | 33 | 2268859 | 1 | 1 | |
| 2026-03-09 | 10-K | 10-K | 0001193125-26-098530 | 001-37348 | 26735155 | 34 | 19801376 | 1 | 1 | |
| 2026-03-09 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-26-097582 | 001-37348 | 26733209 | 34 | 23682090 | 1 | 1 |
| 2026-03-04 | 4 | 4 | 0001193125-26-091647 | 5808 | ||||||
| 2026-03-02 | 144 | xsl144X01/primary_doc.xml | 0001972481-26-000071 | 001-37348 | 26707610 | 33 | 4973 | |||
| 2026-02-25 | 8-K | 8-K | 7.01,9.01 | 0001193125-26-068566 | 001-37348 | 26674234 | 34 | 22896294 | 1 | 1 |
| 2026-02-18 | 4 | 4 | 0001193125-26-057174 | 5791 | ||||||
| 2026-02-18 | 4 | 4 | 0001193125-26-057168 | 5879 | ||||||
| 2026-02-18 | 4 | 4 | 0001193125-26-057159 | 5878 | ||||||
| 2026-02-13 | 144 | xsl144X01/primary_doc.xml | 0001972481-26-000054 | 001-37348 | 26632437 | 33 | 4473 | |||
| 2026-02-10 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001214659-26-001397 | 005-88716 | 26614833 | 34 | 10871 | |||
| 2026-02-04 | 4 | 4 | 0001193125-26-037647 | 5808 | ||||||
| 2026-02-04 | 4 | 4 | 0001193125-26-037643 | 5792 | ||||||
| 2026-01-16 | 4 | 4 | 0001193125-26-015429 | 8239 | ||||||
| 2026-01-16 | 4 | 4 | 0001193125-26-015427 | 8188 | ||||||
| 2026-01-16 | 4 | 4 | 0001193125-26-015426 | 8187 | ||||||
| 2026-01-16 | 4 | 4 | 0001193125-26-015430 | 8223 | ||||||
| 2026-01-16 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001716774-26-000003 | 005-88716 | 26537956 | 34 | 8743 | |||
| 2026-01-12 | 8-K | 8-K | 7.01,9.01 | 0001193125-26-009758 | 001-37348 | 26524663 | 34 | 22451187 | 1 | 1 |
| 2025-12-18 | 8-K | 8-K | 5.02 | 0001193125-25-324796 | 001-37348 | 251583059 | 34 | 155856 | 1 | 1 |
| 2025-12-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000929638-25-004599 | 005-88716 | 251571859 | 34 | 8974 | |||
| 2025-12-15 | 4 | xslF345X05/form4.xml | 0000929638-25-004597 | 9249 | ||||||
| 2025-12-11 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-25-315039 | 001-37348 | 251563512 | 34 | 21032563 | 1 | 1 |
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-004964 | 005-88716 | 251483989 | 34 | 11024 | |||
| 2025-11-12 | 10-Q | 10-Q | 0001193125-25-277748 | 001-37348 | 251473448 | 34 | 9285621 | 1 | 1 | |
| 2025-11-12 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-110417 | 005-88716 | 251473173 | 34 | 26813 | |||
| 2025-11-12 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-25-276062 | 001-37348 | 251469167 | 34 | 428647 | 1 | 1 |
| 2025-11-03 | 8-K | 8-K | 1.01,7.01,9.01 | 0001193125-25-261722 | 001-37348 | 251442173 | 34 | 1005701 | 1 | 1 |
| 2025-11-03 | 424B5 | 424B5 | 0001193125-25-261717 | 333-277888 | 251442161 | 33 | 976893 | |||
| 2025-10-30 | 8-K | 8-K | 8.01 | 0001193125-25-258692 | 001-37348 | 251436263 | 34 | 159911 | 1 | 1 |
| 2025-10-30 | 424B5 | 424B5 | 0001193125-25-258685 | 333-277888 | 251436245 | 33 | 971185 | |||
| 2025-10-27 | 4 | 4 | 0001193125-25-251639 | 14774 | ||||||
| 2025-10-27 | 4 | 4 | 0001193125-25-251635 | 9296 | ||||||
| 2025-10-24 | 144 | xsl144X01/primary_doc.xml | 0001972481-25-000257 | 001-37348 | 251416427 | 33 | 4474 | |||
| 2025-10-24 | 144 | xsl144X01/primary_doc.xml | 0001972481-25-000256 | 001-37348 | 251416361 | 33 | 4477 | |||
| 2025-10-21 | 4 | 4 | 0001193125-25-245262 | 8566 | ||||||
| 2025-10-20 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-25-243046 | 001-37348 | 251402341 | 34 | 19553209 | 1 | 1 |
| 2025-09-16 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-25-204389 | 001-37348 | 251315933 | 34 | 187685 | 1 | 1 |
| 2025-08-05 | 10-Q | 10-Q | 0000950170-25-103118 | 001-37348 | 251185453 | 34 | 8968504 | 1 | 1 | |
| 2025-08-05 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-25-102447 | 001-37348 | 251183129 | 34 | 425041 | 1 | 1 |
| 2025-07-29 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000932471-25-000833 | 005-88716 | 251159137 | 34 | 6302 | |||
| 2025-07-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002052113-25-002503 | 005-88716 | 251128447 | 34 | 10846 | |||
| 2025-06-02 | 4 | 4 | 0000950170-25-080313 | 7266 | ||||||
| 2025-06-02 | 4 | 4 | 0000950170-25-080311 | 9356 | ||||||
| 2025-06-02 | 4 | 4 | 0000950170-25-080312 | 7176 | ||||||
| 2025-06-02 | 4 | 4 | 0000950170-25-080310 | 9293 | ||||||
| 2025-06-02 | 4 | 4 | 0000950170-25-080309 | 7244 | ||||||
| 2025-06-02 | 4 | 4 | 0000950170-25-080308 | 7270 | ||||||
| 2025-05-19 | 8-K | 8-K | 5.07,8.01 | 0000950170-25-073967 | 001-37348 | 25961577 | 34 | 194380 | 1 | 1 |
| 2025-05-06 | 10-Q | 10-Q | 0000950170-25-064507 | 001-37348 | 25917583 | 34 | 8406661 | 1 | 1 | |
| 2025-05-06 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-25-063990 | 001-37348 | 25915384 | 34 | 377716 | 1 | 1 |
| 2025-04-01 | ARS | ARS | 0000950170-25-048613 | 001-37348 | 25800352 | 34 | 5329766 | |||
| 2025-04-01 | DEFA14A | DEFA14A | 0000950170-25-048607 | 001-37348 | 25800330 | 34 | 245010 | |||
| 2025-04-01 | DEF 14A | DEF 14A | 0000950170-25-048603 | 001-37348 | 25800306 | 34 | 8416483 | 1 | 1 | |
| 2025-03-21 | 8-K | 8-K | 5.02 | 0000950170-25-043276 | 001-37348 | 25761088 | 34 | 164692 | 1 | 1 |
| 2025-03-18 | 3 | 3 | 0000950170-25-041301 | 22840 | ||||||
| 2025-03-18 | 8-K | 8-K | 5.02,9.01 | 0000950170-25-041254 | 001-37348 | 25748860 | 34 | 559561 | 1 | 1 |
| 2025-03-11 | 10-K | 10-K | 0000950170-25-037335 | 001-37348 | 25728858 | 34 | 19214933 | 1 | 1 | |
| 2025-03-11 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-25-036838 | 001-37348 | 25725949 | 34 | 434101 | 1 | 1 |
| 2025-03-07 | 4 | 4 | 0000950170-25-035547 | 5817 | ||||||
| 2025-03-06 | 144 | xsl144X01/primary_doc.xml | 0001972481-25-000048 | 001-37348 | 25715140 | 33 | 4388 | |||
| 2025-02-18 | 4 | 4 | 0000950170-25-022514 | 5836 | ||||||
| 2025-02-18 | 4 | 4 | 0000950170-25-022512 | 5883 | ||||||
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000947871-25-000162 | 005-88716 | 25629581 | 34 | 15809 | |||
| 2025-02-14 | 144 | xsl144X01/primary_doc.xml | 0001972481-25-000032 | 001-37348 | 25629137 | 33 | 4431 | |||
| 2025-02-14 | 144 | xsl144X01/primary_doc.xml | 0001972481-25-000031 | 001-37348 | 25629047 | 33 | 4477 | |||
| 2025-02-14 | 8-K | 8-K | 7.01,8.01,9.01 | 0000950170-25-020424 | 001-37348 | 25623340 | 34 | 23234616 | 1 | 1 |
| 2025-02-04 | 4 | 4 | 0000950170-25-013704 | 8248 | ||||||
| 2025-02-04 | 4 | 4 | 0000950170-25-013702 | 8145 | ||||||
| 2025-02-04 | 4 | 4 | 0000950170-25-013697 | 8195 | ||||||
| 2024-12-03 | 8-K | 8-K | 7.01,8.01,9.01 | 0000950170-24-132458 | 001-37348 | 241521174 | 34 | 189344 | 1 | 1 |
| 2024-11-15 | 8-K | 8-K | 8.01 | 0000950170-24-127644 | 001-37348 | 241468442 | 34 | 159898 | 1 | 1 |
| 2024-11-14 | SC 13G/A | CORBUS PHARMACEUTICALS HOLDINGS, INC. | 0000902664-24-006642 | 005-88716 | 241465286 | 34 | 56407 | |||
| 2024-11-14 | SC 13G | SCHEDULE 13G | 0000947871-24-000914 | 005-88716 | 241465059 | 34 | 68772 | |||
| 2024-11-14 | SC 13G/A | SC 13G/A | 0001140361-24-046892 | 005-88716 | 241461896 | 34 | 117313 | |||
| 2024-11-14 | SC 13G/A | AMENDMENT NO. 1 | 0001214659-24-019105 | 005-88716 | 241461366 | 34 | 81642 | |||
| 2024-11-14 | SC 13G/A | cormorant-crbp093024a2.htm | 0001172661-24-005058 | 005-88716 | 241460791 | 34 | 86526 | |||
| 2024-11-12 | SC 13G/A | UnitedStates_13G__CorbusPhar.txt | 0000932471-24-000998 | 005-88716 | 241447047 | 34 | 6631 | |||
| 2024-11-12 | SC 13G/A | CORBUS PHARMACEUTICALS HOLDINGS, INC. | 0000902664-24-006420 | 005-88716 | 241444282 | 34 | 72172 | |||
| 2024-11-08 | SC 13G | us21833p3010_110824.txt | 0002012383-24-003579 | 005-88716 | 241439740 | 34 | 13775 | |||
| 2024-11-07 | 10-Q | 10-Q | 0000950170-24-123486 | 001-37348 | 241436859 | 34 | 8166031 | 1 | 1 | |
| 2024-11-07 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-24-122839 | 001-37348 | 241433387 | 34 | 26461488 | 1 | 1 |
| 2024-11-04 | SC 13G/A | UnitedStates_13G__CorbusPhar.txt | 0000932471-24-000364 | 005-88716 | 241421525 | 34 | 5680 | |||
| 2024-11-04 | 8-K | 8-K | 7.01,8.01,9.01 | 0000950170-24-120289 | 001-37348 | 241420778 | 34 | 26274604 | 1 | 1 |
| 2024-10-22 | SC 13G | us21833p3010_102224.txt | 0002012383-24-001592 | 005-88716 | 241387292 | 34 | 13765 | |||
| 2024-10-15 | SC 13G/A | CRBP_SC13GA1.htm | 0001273087-24-000100 | 005-88716 | 241372049 | 34 | 81806 | |||
| 2024-10-11 | SC 13G | crbp1011241sc13g.htm | 0001214659-24-017478 | 005-88716 | 241367542 | 34 | 68831 | |||
| 2024-09-24 | 4 | xslF345X05/form4.xml | 0000929638-24-003217 | 19438 | ||||||
| 2024-09-04 | 144 | xsl144X01/primary_doc.xml | 0001972481-24-000218 | 001-37348 | 241278127 | 33 | 4307 | |||
| 2024-09-03 | 8-K | 8-K | 8.01 | 0000950170-24-102878 | 001-37348 | 241274781 | 34 | 159887 | 1 | 1 |
| 2024-08-20 | 4 | 4 | 0000950170-24-099175 | 7315 | ||||||
| 2024-08-20 | 3 | 3 | 0000950170-24-099169 | 12587 | ||||||
| 2024-08-20 | 8-K | 8-K | 5.02,7.01,9.01 | 0000950170-24-098861 | 001-37348 | 241222772 | 34 | 202982 | 1 | 1 |
| 2024-08-06 | 8-K | 8-K | 7.01,9.01 | 0000950170-24-091931 | 001-37348 | 241180041 | 34 | 33698346 | 1 | 1 |
| 2024-08-06 | 10-Q | 10-Q | 0000950170-24-091922 | 001-37348 | 241179989 | 34 | 8214343 | 1 | 1 | |
| 2024-08-06 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-24-091219 | 001-37348 | 241177195 | 34 | 388609 | 1 | 1 |
| 2024-06-18 | 4 | 4 | 0000950170-24-075075 | 26006 | ||||||
| 2024-06-18 | 4 | 4 | 0000950170-24-075071 | 42623 | ||||||
| 2024-06-17 | 8-K | 8-K | 8.01 | 0000950170-24-074032 | 001-37348 | 241047117 | 34 | 148868 | 1 | 1 |
| 2024-06-14 | 144 | xsl144X01/primary_doc.xml | 0001972481-24-000152 | 001-37348 | 241046091 | 33 | 5448 | |||
| 2024-06-14 | 144 | xsl144X01/primary_doc.xml | 0001972481-24-000151 | 001-37348 | 241046085 | 33 | 6022 | |||
| 2024-06-14 | 4 | 4 | 0000950170-24-073710 | 16445 | ||||||
| 2024-06-03 | 4 | 4 | 0000950170-24-068039 | 14504 | ||||||
| 2024-06-03 | 4 | 4 | 0000950170-24-068035 | 14435 | ||||||
| 2024-06-03 | 4 | 4 | 0000950170-24-068030 | 14269 | ||||||
| 2024-06-03 | 4 | 4 | 0000950170-24-068014 | 14341 | ||||||
| 2024-06-03 | 4 | 4 | 0000950170-24-068013 | 14236 | ||||||
| 2024-06-03 | 4 | 4 | 0000950170-24-068009 | 14487 | ||||||
| 2024-06-03 | 4 | 4 | 0000950170-24-068005 | 14260 | ||||||
| 2024-06-03 | 8-K | 8-K | 7.01,8.01,9.01 | 0000950170-24-067651 | 001-37348 | 241011969 | 34 | 32427850 | 1 | 1 |
| 2024-05-31 | S-8 | S-8 | 0000950170-24-067373 | 333-279883 | 241010385 | 33 | 443497 | |||
| 2024-05-20 | 4 | FORM 4 SUBMISSION | 0001209191-24-005676 | 5535 | ||||||
| 2024-05-20 | 4 | FORM 4 SUBMISSION | 0001209191-24-005675 | 5594 | ||||||
| 2024-05-20 | 4 | FORM 4 SUBMISSION | 0001209191-24-005674 | 5566 | ||||||
| 2024-05-20 | 4 | FORM 4 SUBMISSION | 0001209191-24-005673 | 5579 | ||||||
| 2024-05-20 | 4 | FORM 4 SUBMISSION | 0001209191-24-005672 | 5525 | ||||||
| 2024-05-20 | 4 | FORM 4 SUBMISSION | 0001209191-24-005671 | 5467 | ||||||
| 2024-05-20 | 4 | FORM 4 SUBMISSION | 0001209191-24-005670 | 5487 | ||||||
| 2024-05-20 | 8-K | 8-K | 5.02,5.07,9.01 | 0000950170-24-062436 | 001-37348 | 24965028 | 34 | 760531 | 1 | 1 |
| 2024-05-09 | 8-K | 8-K | 8.01 | 0000950170-24-056291 | 001-37348 | 24928660 | 34 | 192951 | 1 | 1 |
| 2024-05-08 | 144 | xsl144X01/primary_doc.xml | 0001972481-24-000108 | 001-37348 | 24925775 | 33 | 5374 | |||
| 2024-05-07 | 10-Q | 10-Q | 0000950170-24-054625 | 001-37348 | 24922615 | 34 | 7914297 | 1 | 1 | |
| 2024-05-07 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-24-053978 | 001-37348 | 24919771 | 34 | 337531 | 1 | 1 |
| 2024-04-11 | 4 | FORM 4 SUBMISSION | 0001209191-24-005284 | 7962 | ||||||
| 2024-04-10 | DEFA14A | DEFA14A | 0000950170-24-043418 | 001-37348 | 24836474 | 34 | 42294 | |||
| 2024-04-10 | 8-K | 8-K | 5.02,9.01 | 0000950170-24-043417 | 001-37348 | 24836466 | 34 | 650923 | 1 | 1 |
| 2024-04-02 | ARS | ARS | 0000950170-24-040250 | 001-37348 | 24814931 | 34 | 2287293 | |||
| 2024-04-02 | DEFA14A | DEFA14A | 0000950170-24-040247 | 001-37348 | 24814889 | 34 | 171148 | |||
| 2024-04-02 | DEF 14A | DEF 14A | 0000950170-24-040242 | 001-37348 | 24814853 | 34 | 2429480 | 1 | 1 | |
| 2024-03-22 | PRE 14A | PRE 14A | 0000950170-24-035466 | 001-37348 | 24776108 | 34 | 1368431 | |||
| 2024-03-20 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-03-20 16:15:00 | 9999999995-24-000696 | 333-277888 | 24769286 | 33 | 1841 | ||
| 2024-03-20 | 8-K | 8-K | 8.01 | 0000950170-24-034271 | 001-37348 | 24768562 | 34 | 148672 | 1 | 1 |
| 2024-03-20 | 10-K/A | 10-K/A | 0000950170-24-034266 | 001-37348 | 24768533 | 34 | 3022030 | 1 | 1 | |
| 2024-03-20 | 424B3 | 424B3 | 0000950170-24-034262 | 333-277888 | 24768513 | 33 | 245480 | |||
| 2024-03-18 | SC 13G/A | AMENDMENT NO. 1 | 0000929638-24-001033 | 005-88716 | 24759136 | 34 | 98492 | |||
| 2024-03-18 | CORRESP | filename1.htm | 0000950170-24-032536 | 16319 | ||||||
| 2024-03-15 | UPLOAD | filename1.pdf | 0000000000-24-002905 | 333-277888 | 40428 | |||||
| 2024-03-13 | S-3 | S-3 | 0000950170-24-030848 | 333-277888 | 24746701 | 33 | 2068350 | |||
| 2024-03-12 | 10-K | 10-K | 0000950170-24-030133 | 001-37348 | 24743408 | 34 | 13451345 | 1 | 1 | |
| 2024-03-12 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-24-029667 | 001-37348 | 24740272 | 34 | 341472 | 1 | 1 |
| 2024-03-11 | 4 | xslF345X05/form4.xml | 0000929638-24-000985 | 27651 | ||||||
| 2024-02-29 | 4 | FORM 4 SUBMISSION | 0001209191-24-004120 | 11468 | ||||||
| 2024-02-29 | 3 | FORM 3 SUBMISSION | 0001209191-24-004119 | 6237 | ||||||
| 2024-02-28 | SC 13G | CRBP_SC13G_2024.htm | 0001273087-24-000053 | 005-88716 | 24696175 | 34 | 81901 | |||
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001140361-24-008026 | 005-88716 | 24639629 | 34 | 122863 | |||
| 2024-02-14 | SC 13G | SC 13G | 0001140361-24-008023 | 005-88716 | 24639533 | 34 | 116434 | |||
| 2024-02-14 | SC 13G | SC 13G | 0001104659-24-023629 | 005-88716 | 24637996 | 34 | 68127 | |||
| 2024-02-14 | 4 | FORM 4 SUBMISSION | 0001209191-24-003337 | 8350 | ||||||
| 2024-02-14 | 4 | FORM 4 SUBMISSION | 0001209191-24-003336 | 8396 | ||||||
| 2024-02-12 | SC 13G | CORBUS PHARMACEUTICALS HOLDINGS, INC. | 0000902664-24-001435 | 005-88716 | 24620710 | 34 | 100581 | |||
| 2024-02-12 | SC 13G | SC 13G | 0001104659-24-014646 | 005-88716 | 24620199 | 34 | 87197 | |||
| 2024-02-09 | SC 13G | CRBP_SC13G.htm | 0001319244-24-000026 | 005-88716 | 24614987 | 34 | 96408 | |||
| 2024-02-06 | 8-K | 8-K | 5.02 | 0000950170-24-011733 | 001-37348 | 24600397 | 34 | 146527 | 1 | 1 |
| 2024-02-06 | 4 | xslF345X05/form4.xml | 0000929638-24-000383 | 8550 | ||||||
| 2024-02-05 | SC 13G | sch13g.htm | 0000929638-24-000374 | 005-88716 | 24596458 | 34 | 110807 | |||
| 2024-02-05 | SC 13G | SC 13G | 0001104659-24-010623 | 005-88716 | 24596003 | 34 | 64605 | |||
| 2024-02-05 | 8-K | 8-K | 7.01,9.01 | 0000950170-24-011013 | 001-37348 | 24594010 | 34 | 29064373 | 1 | 1 |
| 2024-02-02 | 8-K/A | 8-K/A | 9.01 | 0000950170-24-009973 | 001-37348 | 24588576 | 34 | 187679 | 1 | 1 |
| 2024-02-01 | 8-K | 8-K | 1.01,7.01,9.01 | 0000950170-24-009874 | 001-37348 | 24588016 | 34 | 668887 | 1 | 1 |
| 2024-02-01 | 424B5 | 424B5 | 0000950170-24-009865 | 333-272314 | 24587844 | 33 | 850329 | |||
| 2024-01-31 | S-3MEF | S-3MEF | 0000950170-24-009164 | 333-276776 | 24580819 | 33 | 188606 | |||
| 2024-01-31 | 8-K | 8-K | 8.01 | 0000950170-24-009086 | 001-37348 | 24580328 | 34 | 147913 | 1 | 1 |
| 2024-01-31 | 424B5 | 424B5 | 0000950170-24-009084 | 333-272314 | 24580327 | 33 | 847736 | |||
| 2024-01-30 | 4 | FORM 4 SUBMISSION | 0001209191-24-002449 | 7190 | ||||||
| 2024-01-30 | 4 | FORM 4 SUBMISSION | 0001209191-24-002419 | 6957 | ||||||
| 2024-01-30 | 4 | xslF345X05/form4.xml | 0000929638-24-000304 | 35860 | ||||||
| 2024-01-30 | 3 | xslF345X02/form3.xml | 0000929638-24-000303 | 7906 | ||||||
| 2024-01-29 | SC 13G | CORBUS PHARMACEUTICALS HOLDINGS, INC. | 0000902664-24-000754 | 005-88716 | 24574229 | 34 | 70644 | |||
| 2024-01-29 | 8-K | 8-K | 8.01 | 0000950170-24-008129 | 001-37348 | 24570104 | 34 | 150014 | 1 | 1 |
| 2024-01-29 | 424B3 | 424B3 | 0000950170-24-008127 | 333-272314 | 24570097 | 33 | 25851 | |||
| 2024-01-26 | SC 13G | g126243sc13g.htm | 0001214659-24-001240 | 005-88716 | 24568297 | 34 | 84970 | |||
| 2024-01-26 | 8-K | 8-K | 7.01,8.01,9.01 | 0000950170-24-007703 | 001-37348 | 24564221 | 34 | 28703361 | 1 | 1 |
| 2024-01-09 | 8-K | 8-K | 3.01,7.01,8.01,9.01 | 0000950170-24-003197 | 001-37348 | 24521811 | 34 | 189711 | 1 | 1 |
| 2023-11-14 | 8-K | 8-K | 7.01,9.01 | 0000950170-23-063854 | 001-37348 | 231408011 | 34 | 25382187 | 1 | 1 |
| 2023-11-13 | 8-K | 8-K | 3.01,8.01 | 0000950170-23-063134 | 001-37348 | 231400182 | 34 | 171347 | 1 | 1 |
| 2023-11-07 | 10-Q | 10-Q | 0000950170-23-060377 | 001-37348 | 231384884 | 34 | 10119899 | 1 | 1 | |
| 2023-11-07 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-23-059812 | 001-37348 | 231382083 | 34 | 487197 | 1 | 1 |
| 2023-08-08 | 10-Q | 10-Q | 0000950170-23-039960 | 001-37348 | 231152599 | 34 | 10865668 | 1 | 1 | |
| 2023-08-08 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-23-039409 | 001-37348 | 231149558 | 34 | 526210 | 1 | 1 |
| 2023-08-03 | 8-K | 8-K | 8.01,9.01 | 0000950170-23-037620 | 001-37348 | 231138269 | 34 | 21375153 | 1 | 1 |
| 2023-06-13 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2023-06-13 16:15:00 | 9999999995-23-001739 | 333-272314 | 231012884 | 33 | 1793 | ||
| 2023-06-13 | 424B3 | 424B3 | 0000950170-23-027746 | 333-272314 | 231011993 | 33 | 334300 | |||
| 2023-06-12 | S-3/A | S-3/A | 0001193125-23-165391 | 333-272314 | 231008816 | 33 | 395597 | |||
| 2023-06-07 | CORRESP | filename1.htm | 0000950170-23-026822 | 23349 | ||||||
| 2023-06-07 | UPLOAD | filename1.pdf | 0000000000-23-006053 | 40296 | ||||||
| 2023-06-01 | S-3 | S-3 | 0001193125-23-158143 | 333-272314 | 23982805 | 33 | 1225799 | |||
| 2023-05-22 | 4 | FORM 4 SUBMISSION | 0001209191-23-031474 | 5404 | ||||||
| 2023-05-22 | 4 | FORM 4 SUBMISSION | 0001209191-23-031471 | 5510 | ||||||
| 2023-05-22 | 4 | FORM 4 SUBMISSION | 0001209191-23-031467 | 5482 | ||||||
| 2023-05-22 | 4 | FORM 4 SUBMISSION | 0001209191-23-031460 | 5451 | ||||||
| 2023-05-22 | 4 | FORM 4 SUBMISSION | 0001209191-23-031453 | 5495 | ||||||
| 2023-05-22 | 4 | FORM 4 SUBMISSION | 0001209191-23-031448 | 5383 | ||||||
| 2023-05-22 | 4 | FORM 4 SUBMISSION | 0001209191-23-031441 | 5441 | ||||||
| 2023-05-19 | 8-K | 8-K | 5.07 | 0000950170-23-023162 | 001-37348 | 23938007 | 34 | 217223 | 1 | 1 |
| 2023-05-09 | 10-Q | 10-Q | 0000950170-23-019825 | 001-37348 | 23903122 | 34 | 9793740 | 1 | 1 | |
| 2023-05-09 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-23-019170 | 001-37348 | 23900124 | 34 | 440588 | 1 | 1 |
| 2023-04-24 | 8-K/A | 8-K/A | 5.02,9.01 | 0000950170-23-014119 | 001-37348 | 23840594 | 34 | 289786 | 1 | 1 |
| 2023-04-03 | DEF 14A | DEF 14A | 0000950170-23-011611 | 001-37348 | 23793193 | 34 | 2331463 | 1 | 1 | |
| 2023-04-03 | ARS | ARS | 0000950170-23-011609 | 001-37348 | 23793188 | 34 | 4055614 | |||
| 2023-04-03 | DEFA14A | DEFA14A | 0000950170-23-011610 | 001-37348 | 23793186 | 34 | 184622 | |||
| 2023-03-10 | S-8 | S-8 | 0000950170-23-007308 | 333-270468 | 23724153 | 33 | 291597 | |||
| 2023-03-07 | 10-K | 10-K | 0000950170-23-006469 | 001-37348 | 23712990 | 34 | 17943828 | 1 | 1 | |
| 2023-03-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-016575 | 5383 | ||||||
| 2023-03-07 | 3 | FORM 3 SUBMISSION | 0001209191-23-016574 | 2867 | ||||||
| 2023-03-07 | 8-K | 8-K | 2.02,5.02,7.01,8.01,9.01 | 0000950170-23-006385 | 001-37348 | 23711165 | 34 | 19874008 | 1 | 1 |
| 2023-03-06 | 8-K | 8-K | 5.02,7.01,9.01 | 0000950170-23-006132 | 001-37348 | 23707735 | 34 | 207104 | 1 | 1 |
| 2023-02-15 | 4 | FORM 4 SUBMISSION | 0001209191-23-009635 | 5525 | ||||||
| 2023-02-15 | 4 | FORM 4 SUBMISSION | 0001209191-23-009634 | 5577 | ||||||
| 2023-02-15 | 4 | FORM 4 SUBMISSION | 0001209191-23-009633 | 5551 | ||||||
| 2023-02-15 | 4 | FORM 4 SUBMISSION | 0001209191-23-009631 | 5600 | ||||||
| 2023-02-15 | 8-K/A | 8-K/A | 3.03 | 0000950170-23-002815 | 001-37348 | 23632482 | 34 | 173046 | 1 | 1 |
| 2023-02-13 | 8-K | 8-K | 1.01,5.03,7.01,8.01,9.01 | 0000950170-23-002534 | 001-37348 | 23614790 | 34 | 18404222 | 1 | 1 |
| 2023-01-06 | 8-K | 8-K | 3.01,8.01 | 0000950170-23-000351 | 001-37348 | 23515717 | 34 | 179987 | 1 | 1 |
| 2022-12-21 | 8-K | 8-K | 5.07 | 0000950170-22-026875 | 001-37348 | 221478886 | 34 | 183819 | 1 | 1 |
| 2022-12-21 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-22-026872 | 001-37348 | 221478830 | 34 | 543309 | 1 | 1 |
| 2022-11-14 | DEF 14A | DEF 14A | 0000950170-22-025075 | 001-37348 | 221387865 | 34 | 418382 | |||
| 2022-11-08 | 10-Q | 10-Q | 0000950170-22-023282 | 001-37348 | 221369468 | 34 | 10425389 | 1 | 1 | |
| 2022-11-04 | PRE 14A | PRE 14A | 0000950170-22-022213 | 001-37348 | 221362870 | 34 | 409168 | |||
| 2022-10-31 | 8-K | 8-K | 1.01,9.01 | 0000950170-22-020636 | 001-37348 | 221347311 | 34 | 267387 | 1 | 1 |
| 2022-10-12 | 8-A12G | 8-A12G | 0000950170-22-019507 | 000-55327 | 221307380 | 34 | 89501 | |||
| 2022-10-12 | 8-K | 8-K | 3.03,5.03,9.01 | 0000950170-22-019502 | 001-37348 | 221307209 | 34 | 277765 | 1 | 1 |
| 2022-09-28 | 4 | FORM 4 SUBMISSION | 0001209191-22-051425 | 5411 | ||||||
| 2022-09-28 | 3 | FORM 3 SUBMISSION | 0001209191-22-051423 | 2887 | ||||||
| 2022-09-26 | 8-K | 8-K | 5.02,7.01,9.01 | 0000950170-22-018857 | 001-37348 | 221266470 | 34 | 200457 | 1 | 1 |
| 2022-08-24 | SC 13G/A | AMENDMENT NO. 18 TO SCHEDULE 13G | 0001213900-22-050731 | 005-88716 | 221190916 | 34 | 43209 | |||
| 2022-08-12 | 4 | FORM 4 SUBMISSION | 0001209191-22-045524 | 4606 | ||||||
| 2022-08-11 | 4 | FORM 4 SUBMISSION | 0001209191-22-045358 | 4625 | ||||||
| 2022-08-10 | 4 | FORM 4 SUBMISSION | 0001209191-22-045137 | 4582 | ||||||
| 2022-08-09 | 10-Q | 10-Q | 0000950170-22-016150 | 001-37348 | 221149271 | 34 | 9756053 | 1 | 1 | |
| 2022-08-09 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-22-015864 | 001-37348 | 221147212 | 34 | 539855 | 1 | 1 |
| 2022-07-07 | 8-K | 8-K | 3.01,8.01 | 0000950170-22-012529 | 001-37348 | 221072301 | 34 | 169449 | 1 | 1 |
| 2022-06-08 | 8-K | 8-K | 8.01,9.01 | 0000950170-22-011301 | 001-37348 | 221002640 | 34 | 2638846 | 1 | 1 |
| 2022-05-23 | 8-K | 8-K | 5.07 | 0000950170-22-010506 | 001-37348 | 22952589 | 34 | 203855 | 1 | 1 |
| 2022-05-19 | 4 | FORM 4 SUBMISSION | 0001209191-22-030447 | 5485 | ||||||
| 2022-05-19 | 4 | FORM 4 SUBMISSION | 0001209191-22-030446 | 5498 | ||||||
| 2022-05-19 | 4 | FORM 4 SUBMISSION | 0001209191-22-030445 | 5513 | ||||||
| 2022-05-19 | 4 | FORM 4 SUBMISSION | 0001209191-22-030444 | 5454 | ||||||
| 2022-05-19 | 4 | FORM 4 SUBMISSION | 0001209191-22-030437 | 5444 | ||||||
| 2022-05-17 | 8-K | 8-K | 8.01 | 0000950170-22-010202 | 001-37348 | 22935559 | 34 | 164772 | 1 | 1 |
| 2022-05-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-029031 | 4579 | ||||||
| 2022-05-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-029030 | 4624 | ||||||
| 2022-05-10 | 10-Q | 10-Q | 0000950170-22-009050 | 001-37348 | 22910824 | 34 | 9447505 | 1 | 1 | |
| 2022-05-10 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-22-008743 | 001-37348 | 22907492 | 34 | 442741 | 1 | 1 |
| 2022-04-15 | 8-K | 8-K | 5.02,9.01 | 0000950170-22-005730 | 001-37348 | 22830327 | 34 | 1047588 | 1 | 1 |
| 2022-04-11 | 8-K | 8-K | 7.01,8.01,9.01 | 0000950170-22-005547 | 001-37348 | 22818645 | 34 | 8660730 | 1 | 1 |
| 2022-04-01 | DEFA14A | DEFA14A | 0000950170-22-005264 | 001-37348 | 22795870 | 34 | 550154 | |||
| 2022-04-01 | DEF 14A | DEF 14A | 0000950170-22-005263 | 001-37348 | 22795845 | 34 | 1384996 | |||
| 2022-03-15 | S-8 | S-8 | 0001193125-22-076252 | 333-263583 | 22742051 | 33 | 72327 | |||
| 2022-03-11 | 4 | FORM 4 SUBMISSION | 0001209191-22-018101 | 4604 | ||||||
| 2022-03-10 | 4 | FORM 4 SUBMISSION | 0001209191-22-017781 | 4579 | ||||||
| 2022-03-09 | 4 | FORM 4 SUBMISSION | 0001209191-22-017449 | 4623 | ||||||
| 2022-03-08 | 10-K | 10-K | 0000950170-22-003145 | 001-37348 | 22722577 | 34 | 12153653 | 1 | 1 | |
| 2022-03-08 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-22-003066 | 001-37348 | 22720384 | 34 | 452748 | 1 | 1 |
| 2022-02-14 | SC 13G/A | AMENDMENT NO. 17 TO SCHEDULE 13G | 0001213900-22-007461 | 005-88716 | 22630960 | 34 | 48212 | |||
| 2022-02-02 | 4 | FORM 4 SUBMISSION | 0001209191-22-006519 | 5575 | ||||||
| 2022-02-02 | 4 | FORM 4 SUBMISSION | 0001209191-22-006515 | 5598 | ||||||
| 2022-02-02 | 4 | FORM 4 SUBMISSION | 0001209191-22-006511 | 5520 | ||||||
| 2022-02-02 | 4 | FORM 4 SUBMISSION | 0001209191-22-006505 | 5550 | ||||||
| 2022-01-03 | 8-K | 8-K | 3.01 | 0000950170-22-000021 | 001-37348 | 22502833 | 34 | 166101 | 1 | 1 |
| 2021-12-08 | 4 | FORM 4 SUBMISSION | 0001209191-21-068508 | 5556 | ||||||
| 2021-12-08 | 3 | FORM 3 SUBMISSION | 0001209191-21-068503 | 6041 | ||||||
| 2021-11-12 | 10-Q | 10-Q | 0000950170-21-004269 | 001-37348 | 211399924 | 34 | 9363899 | 1 | 1 | |
| 2021-11-12 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-21-004261 | 001-37348 | 211399829 | 34 | 497817 | 1 | 1 |
| 2021-09-28 | 8-K | form8-k.htm | 5.02,9.01 | 0001493152-21-023935 | 001-37348 | 211284010 | 34 | 237710 | 1 | 1 |
| 2021-09-22 | 8-K/A | form8-ka.htm | 5.02,9.01 | 0001493152-21-023317 | 001-37348 | 211268191 | 34 | 291806 | 1 | 1 |
| 2021-08-18 | 8-K | form8-k.htm | 5.02 | 0001493152-21-020508 | 001-37348 | 211185046 | 34 | 206902 | 1 | 1 |
| 2021-08-12 | 10-Q | form10-q.htm | 0001493152-21-019441 | 001-37348 | 211165618 | 34 | 10244586 | 1 | 1 | |
| 2021-08-12 | 8-K | form8-k.htm | 2.02,7.01,9.01 | 0001493152-21-019439 | 001-37348 | 211165591 | 34 | 291073 | 1 | 1 |
| 2021-07-22 | 8-K | form8-k.htm | 8.01,9.01 | 0001493152-21-017498 | 001-37348 | 211106121 | 34 | 19824549 | 1 | 1 |
| 2021-06-24 | 8-K | form8-k.htm | 7.01,8.01,9.01 | 0001493152-21-015154 | 001-37348 | 211040717 | 34 | 400654 | 1 | 1 |
| 2021-06-17 | 4 | FORM 4 SUBMISSION | 0001209191-21-041467 | 7863 | ||||||
| 2021-06-17 | 4 | FORM 4 SUBMISSION | 0001209191-21-041462 | 7922 | ||||||
| 2021-06-17 | 4 | FORM 4 SUBMISSION | 0001209191-21-041461 | 7894 | ||||||
| 2021-06-17 | 4 | FORM 4 SUBMISSION | 0001209191-21-041459 | 7907 | ||||||
| 2021-06-17 | 4 | FORM 4 SUBMISSION | 0001209191-21-041455 | 7853 | ||||||
| 2021-06-17 | 8-K | form8-k.htm | 5.03,5.07,9.01 | 0001493152-21-014663 | 001-37348 | 211025150 | 34 | 550278 | 1 | 1 |
| 2021-06-01 | SC 13G/A | AMENDMENT NO.16 TO SCHEDULE 13G | 0001213900-21-030186 | 005-88716 | 21984314 | 34 | 47538 | |||
| 2021-06-01 | 8-K | form8-k.htm | 1.01,3.02,7.01,8.01,9.01 | 0001493152-21-013297 | 001-37348 | 21982982 | 34 | 13936960 | 1 | 1 |
| 2021-05-19 | DEFA14A | defa14a.htm | 0001493152-21-012193 | 001-37348 | 21938562 | 34 | 33366 | |||
| 2021-05-13 | 10-Q | form10-q.htm | 0001493152-21-011221 | 001-37348 | 21917527 | 34 | 5756940 | 1 | 1 | |
| 2021-05-13 | 8-K | form8-k.htm | 2.02,7.01,9.01 | 0001493152-21-011211 | 001-37348 | 21917323 | 34 | 282916 | 1 | 1 |
| 2021-05-11 | SC 13G/A | AMENDMENT NO.15 TO SCHEDULE 13G | 0001213900-21-025576 | 005-88716 | 21910611 | 34 | 47670 | |||
| 2021-04-12 | SC 13G/A | us21833p1030_040921.txt | 0000834237-21-008113 | 005-88716 | 21818843 | 34 | 12322 | |||
| 2021-04-06 | DEFA14A | formdef14a.htm | 0001493152-21-008111 | 001-37348 | 21809697 | 34 | 750722 | |||
| 2021-04-06 | DEF 14A | formdef14a.htm | 0001493152-21-008107 | 001-37348 | 21809685 | 34 | 1034782 | |||
| 2021-03-26 | PRE 14A | formpre14a.htm | 0001493152-21-006927 | 001-37348 | 21778047 | 34 | 1036033 | |||
| 2021-03-17 | SC 13G/A | AMENDMENT NO. 14 TO SCHEDULE 13G | 0001213900-21-016035 | 005-88716 | 21749838 | 34 | 39248 | |||
| 2021-03-16 | S-8 | forms-8.htm | 0001493152-21-006121 | 333-254350 | 21746421 | 33 | 104105 | |||
| 2021-03-15 | 10-K | form10-k.htm | 0001493152-21-006016 | 001-37348 | 21742621 | 34 | 7041517 | 1 | 1 | |
| 2021-03-15 | 8-K | form8-k.htm | 2.02,5.03,7.01,9.01 | 0001493152-21-005952 | 001-37348 | 21739865 | 34 | 312421 | 1 | 1 |
| 2021-02-16 | SC 13G/A | AMENDMENT NO. 13 TO SCHEDULE 13G | 0001213900-21-009356 | 005-88716 | 21634156 | 34 | 40990 | |||
| 2021-02-12 | SC 13G/A | AMENDMENT NO. 12 TO SCHEDULE 13G | 0001213900-21-008829 | 005-88716 | 21625159 | 34 | 40971 | |||
| 2021-02-04 | 4 | FORM 4 SUBMISSION | 0001209191-21-007742 | 8021 | ||||||
| 2021-02-04 | 4 | FORM 4 SUBMISSION | 0001209191-21-007741 | 8100 | ||||||
| 2021-02-04 | 4 | FORM 4 SUBMISSION | 0001209191-21-007736 | 8081 | ||||||
| 2021-02-04 | 4 | FORM 4 SUBMISSION | 0001209191-21-007727 | 8105 | ||||||
| 2021-02-04 | 8-K | form8-k.htm | 5.02 | 0001493152-21-002634 | 001-37348 | 21591132 | 34 | 211692 | 1 | 1 |
| 2021-01-29 | SC 13G/A | us21833p1030_012821.txt | 0000834237-21-002988 | 005-88716 | 21566918 | 34 | 13208 | |||
| 2021-01-27 | 8-K | form8-k.htm | 8.01,9.01 | 0001493152-21-001868 | 001-37348 | 21556798 | 34 | 5051307 | 1 | 1 |
| 2021-01-11 | SC 13G/A | CorbusPharmaceuticals.txt | 0000093751-21-000006 | 005-88716 | 21519661 | 34 | 8421 | |||
| 2021-01-08 | SC 13G/A | AMENDMENT NO. 11 TO SCHEDULE 13G | 0001213900-21-001112 | 005-88716 | 21516670 | 34 | 49757 | |||
| 2020-12-22 | 4 | FORM 4 SUBMISSION | 0001209191-20-064849 | 14068 | ||||||
| 2020-12-18 | 4 | FORM 4 SUBMISSION | 0001209191-20-064437 | 9310 | ||||||
| 2020-12-11 | SC 13G/A | AMENDMENT NO. 10 TO SCHEDULE 13G | 0001213900-20-042180 | 005-88716 | 201382864 | 34 | 46522 | |||
| 2020-12-04 | 8-K/A | form8-ka.htm | 5.02,9.01 | 0001493152-20-022963 | 001-37348 | 201370123 | 34 | 261361 | 1 | 1 |
| 2020-11-16 | SC 13G/A | AMENDMENT NO. 9 TO SCHEDULE 13G | 0001213900-20-037197 | 005-88716 | 201314828 | 34 | 56443 | |||
| 2020-11-16 | 8-K | form8k.htm | 7.01,9.01 | 0001493152-20-021434 | 001-37348 | 201313815 | 34 | 6935919 | 1 | 1 |
| 2020-11-12 | 4 | FORM 4 SUBMISSION | 0001209191-20-057851 | 4625 | ||||||
| 2020-11-10 | 8-K | form8-k.htm | 2.02,7.01,8.01,9.01 | 0001493152-20-020885 | 001-37348 | 201299820 | 34 | 7368234 | 1 | 1 |
| 2020-11-09 | 10-Q | form10-q.htm | 0001493152-20-020841 | 001-37348 | 201298614 | 34 | 5296343 | 1 | 1 | |
| 2020-11-06 | SC 13G/A | AMENDMENT NO. 8 TO SCHEDULE 13G | 0001213900-20-035462 | 005-88716 | 201292859 | 34 | 50489 | |||
| 2020-10-13 | SC 13G/A | CPHInc.txt | 0000093751-20-000967 | 005-88716 | 201236114 | 34 | 10392 | |||
| 2020-10-08 | 8-K | form8-k.htm | 2.05,5.02,7.01,8.01,9.01 | 0001493152-20-019126 | 001-37348 | 201230284 | 34 | 250280 | 1 | 1 |
| 2020-10-06 | 8-K | form8-k.htm | 7.01,8.01,9.01 | 0001493152-20-018978 | 001-37348 | 201225626 | 34 | 240999 | 1 | 1 |
| 2020-09-25 | 8-K | form8-k.htm | 5.02 | 0001493152-20-018325 | 001-37348 | 201196871 | 34 | 206607 | 1 | 1 |
| 2020-09-15 | 8-K | form8-k.htm | 5.02 | 0001493152-20-017794 | 001-37348 | 201174787 | 34 | 207211 | 1 | 1 |
| 2020-09-08 | 8-K | form8-k.htm | 7.01,8.01,9.01 | 0001493152-20-017365 | 001-37348 | 201163045 | 34 | 274209 | 1 | 1 |
| 2020-08-31 | 10-Q/A | form10-qa.htm | 0001493152-20-017022 | 001-37348 | 201152688 | 34 | 5132891 | 1 | 1 | |
| 2020-08-07 | SC 13G/A | AMENDMENT NO. 7 TO SCHEDULE 13G | 0001213900-20-020809 | 005-88716 | 201084448 | 34 | 44770 | |||
| 2020-08-07 | 424B5 | form424b5.htm | 0001493152-20-014904 | 333-222447 | 201083410 | 33 | 1180030 | |||
| 2020-08-07 | 424B5 | form424b5.htm | 0001493152-20-014902 | 333-237588 | 201083400 | 33 | 1180030 | |||
| 2020-08-06 | 10-Q | form10-q.htm | 0001493152-20-014895 | 001-37348 | 201082902 | 34 | 3958799 | 1 | ||
| 2020-08-06 | 8-K | form8-k.htm | 2.02,7.01,9.01 | 0001493152-20-014810 | 001-37348 | 201079843 | 34 | 202262 | ||
| 2020-07-29 | 8-K | form8-k.htm | 1.01,2.03,3.02,7.01,9.01 | 0001493152-20-014133 | 001-37348 | 201055839 | 34 | 1100179 | ||
| 2020-07-08 | 4 | xslF345X03/ownership.xml | 0001493152-20-012802 | 5466 | ||||||
| 2020-07-08 | 3 | xslF345X02/ownership.xml | 0001493152-20-012801 | 11840 | ||||||
| 2020-07-08 | 8-K | form8-k.htm | 5.02,7.01,9.01 | 0001493152-20-012800 | 001-37348 | 201017305 | 34 | 83978 | ||
| 2020-05-22 | 4 | FORM 4 SUBMISSION | 0001209191-20-031663 | 5411 | ||||||
| 2020-05-22 | 4 | FORM 4 SUBMISSION | 0001209191-20-031662 | 5511 | ||||||
| 2020-05-22 | 4 | FORM 4 SUBMISSION | 0001209191-20-031661 | 5493 | ||||||
| 2020-05-22 | 4 | FORM 4 SUBMISSION | 0001209191-20-031660 | 5546 | ||||||
| 2020-05-22 | 4 | FORM 4 SUBMISSION | 0001209191-20-031659 | 5444 | ||||||
| 2020-05-22 | 4 | FORM 4 SUBMISSION | 0001209191-20-031658 | 5454 | ||||||
| 2020-05-21 | 8-K | form8-k.htm | 5.07 | 0001493152-20-009623 | 001-37348 | 20901882 | 34 | 44624 | ||
| 2020-05-11 | 10-Q | form10-q.htm | 0001493152-20-008248 | 001-37348 | 20865226 | 34 | 3923658 | 1 | ||
| 2020-05-11 | 8-K | form8-k.htm | 2.02,7.01,9.01 | 0001493152-20-008150 | 001-37348 | 20862641 | 34 | 172528 | ||
| 2020-05-04 | 424B3 | form424b3.htm | 0001493152-20-007596 | 333-237588 | 20842875 | 33 | 216141 | |||
| 2020-05-01 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2020-05-01 16:15:00 | 9999999995-20-001005 | 333-237588 | 20842605 | 33 | 1792 | ||
| 2020-04-30 | CORRESP | filename1.htm | 0001493152-20-007445 | 13854 | ||||||
| 2020-04-24 | CORRESP | filename1.htm | 0001493152-20-007096 | 24860 | ||||||
| 2020-04-24 | S-3/A | forms-3a.htm | 0001493152-20-007094 | 333-237588 | 20816252 | 33 | 746020 | |||
| 2020-04-24 | SC 13G/A | AMENDMENT NO. 6 TO SCHEDULE 13G | 0001213900-20-010018 | 005-88716 | 20813200 | 34 | 41466 | |||
| 2020-04-21 | 8-K/A | form8-ka.htm | 5.02,9.01 | 0001493152-20-006836 | 001-37348 | 20805175 | 34 | 36262 |
One latest value per concept from companyfacts (372 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 20.61M | 2026-11-06 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 67.80M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 | |
| invest | InvestmentWarrantsExercisePrice | Investment Warrants, Exercise Price | USD | 1 | 2014-08-01 | 2014-08-31 | 2015 | FY | 10-K | 2016-03-28 | 0001564590-16-015403 |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 4.07M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | AccountsPayableRelatedPartiesCurrent | Accounts Payable, Related Parties, Current | USD | 200,000 | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-08-13 | 0001193125-15-289161 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 30.17M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 1,500 | 2016-06-30 | 2016 | Q2 | 10-Q | 2016-08-12 | 0001493152-16-012283 | |
| us-gaap | AccruedSalariesCurrent | Accrued Salaries, Current | USD | 109,442 | 2016-06-30 | 2016 | Q2 | 10-Q | 2016-08-12 | 0001493152-16-012283 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 4.46M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -196,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 736.14M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 148.89M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-12 | 0001493152-19-003143 | |
| us-gaap | AdjustmentForAmortization | Amortization | USD | 1.25M | 2015-01-01 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-10 | 0001564590-15-010364 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 5.53M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | USD | 11,512 | 2018-07-01 | 2018-09-30 | 2019 | Q3 | 10-Q | 2019-11-07 | 0001493152-19-016601 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalWarrantIssued | Adjustments to Additional Paid in Capital, Warrant Issued | USD | 807,149 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-08 | 0000950170-22-003145 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 5.53M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | AmortizationOfDebtDiscountPremium | Amortization of Debt Discount (Premium) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 15.80M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-15 | 0001493152-21-006016 |
| us-gaap | AreaOfLand | Area of Land | sqft | 6,326 | 2015-12-31 | 2016 | FY | 10-K | 2017-03-08 | 0001493152-17-002256 | |
| us-gaap | AssetImpairmentCharges | Asset Impairment Charges | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | Assets | Assets | USD | 122.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 118.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 0 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-09 | 0000950170-23-019825 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-11 | 0000950170-25-037335 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 85.29M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost | Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five | USD | 0 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-08 | 0000950170-23-039960 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five | USD | 0 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-08 | 0000950170-23-039960 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost | Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One | USD | 81.26M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One | USD | 81.11M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 85.09M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 376,664 | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-15 | 0001493152-21-006016 |
| us-gaap | CapitalLeaseObligationsIncurred | Lease Obligation Incurred | USD | 11,638 | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-03-12 | 0001493152-18-003208 |
| us-gaap | Cash | Cash | USD | 3.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 30.25M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | 6.57M | 2016-01-01 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-10 | 0001493152-16-014751 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 30.63M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 30.63M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | USD | 8.26M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001493152-18-006568 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 1.47M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | CashEquivalentsAtCarryingValue | Cash Equivalents, at Carrying Value | USD | 26.35M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 6.34 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-08 | 0001493152-18-015417 | |
| us-gaap | ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights | Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 2,873 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 | |
| us-gaap | ClassOfWarrantOrRightOutstanding | Class of Warrant or Right, Outstanding | shares | 2.28M | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-08 | 0001493152-18-015417 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 300.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 20.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 20.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | CommonStockShareSubscribedButUnissuedSubscriptionsReceivable | Common Stock, Share Subscribed but Unissued, Subscriptions Receivable | USD | 330,413 | 2016-12-31 | 2017 | FY | 10-K | 2018-03-12 | 0001493152-18-003208 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 2,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -95.90M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | ConstructionInProgressGross | Construction in Progress, Gross | USD | 393,172 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-08 | 0001493152-19-011835 | |
| us-gaap | ContractWithCustomerAssetNet | Contract with Customer, Asset, after Allowance for Credit Loss | USD | 1.62M | 2020-12-31 | 2021 | FY | 10-K | 2022-03-08 | 0000950170-22-003145 | |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 2.48M | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-08 | 0001493152-19-011835 | |
| us-gaap | ContractWithCustomerLiabilityRevenueRecognized | Contract with Customer, Liability, Revenue Recognized | USD | -3.94M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-15 | 0001493152-21-006016 |
| us-gaap | ConversionOfStockAmountConverted1 | Conversion of Stock, Amount Converted | USD | 0 | 2015-01-01 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-10 | 0001564590-15-010364 |
| us-gaap | ConversionOfStockAmountIssued1 | Conversion of Stock, Amount Issued | USD | 1.13M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | 0 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-28 | 0001564590-16-015403 |
| us-gaap | DebtInstrumentCarryingAmount | Long-term Debt, Gross | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-11 | 0000950170-25-037335 | |
| us-gaap | DebtInstrumentConvertibleBeneficialConversionFeature | Debt Instrument, Convertible, Beneficial Conversion Feature | USD | 573,002 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-12 | 0000950170-24-030133 |
| us-gaap | DebtInstrumentFaceAmount | Debt Instrument, Face Amount | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-11 | 0000950170-25-037335 | |
| us-gaap | DebtInstrumentInterestRateStatedPercentage | Debt Instrument, Interest Rate, Stated Percentage | pure | 0.033 | 2014-10-31 | 2015 | Q3 | 10-Q | 2015-11-10 | 0001564590-15-010364 | |
| us-gaap | DebtInstrumentPeriodicPayment | Debt Instrument, Periodic Payment | USD | 24,293 | 2014-10-01 | 2014-10-31 | 2015 | Q3 | 10-Q | 2015-11-10 | 0001564590-15-010364 |
| us-gaap | DebtInstrumentUnamortizedDiscount | Debt Instrument, Unamortized Discount | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-11 | 0000950170-25-037335 | |
| us-gaap | DeferredRentCreditCurrent | Deferred Rent Credit, Current | USD | 35,996 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-16 | 0001493152-20-004077 | |
| us-gaap | DeferredRentCreditNoncurrent | Deferred Rent Credit, Noncurrent | USD | 1.38M | 2018-12-31 | 2019 | FY | 10-K | 2020-03-16 | 0001493152-20-004077 | |
| us-gaap | DeferredRevenue | Deferred Revenue | USD | 1.94M | 2016-12-31 | 2017 | FY | 10-K | 2018-03-12 | 0001493152-18-003208 | |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 270,530 | 2020-06-30 | 2020 | Q2 | 10-Q/A | 2020-08-31 | 0001493152-20-017022 | |
| us-gaap | DeferredRevenueNoncurrent | Deferred Revenue, Noncurrent | USD | 260,260 | 2015-12-31 | 2016 | FY | 10-K | 2017-03-08 | 0001493152-17-002256 | |
| us-gaap | DeferredRevenueRevenueRecognized1 | Deferred Revenue, Revenue Recognized | USD | 2.89M | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-08 | 0001493152-18-015417 |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 127.61M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 78.53M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsForeign | Deferred Tax Assets, Operating Loss Carryforwards, Foreign | USD | 19.66M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal | Deferred Tax Assets, Operating Loss Carryforwards, State and Local | USD | 1.43M | 2017-12-31 | 2018 | FY | 10-K | 2019-03-12 | 0001493152-19-003143 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 887,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwards | Deferred Tax Assets, Tax Credit Carryforwards | USD | 13.33M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 13.50M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 7.24M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities | USD | 409,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 127.61M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 | |
| us-gaap | Depreciation | Depreciation | USD | 200,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 150,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | DerivativeFairValueOfDerivativeLiability | Derivative Liability, Fair Value, Gross Liability | USD | 0 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-06 | 0000950170-24-091922 | |
| us-gaap | DerivativeLiabilitiesCurrent | Derivative Liability, Current | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-11 | 0000950170-25-037335 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -4.87 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.18 | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-09 | 0000950170-22-016150 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -4.87 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | 0.161 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent | pure | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-11 | 0000950170-25-037335 |
| us-gaap | EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount | EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 |
| us-gaap | EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent | EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 |
| us-gaap | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent | pure | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-11 | 0000950170-25-037335 |
| us-gaap | EffectiveIncomeTaxRateReconciliationGiltiPercent | EffectiveIncomeTaxRateReconciliationGiltiPercent | pure | -0.011 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-11 | 0000950170-25-037335 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | 0.007 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | 0.002 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent | pure | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-07 | 0000950170-23-006469 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0.023 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-11 | 0000950170-25-037335 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | -0.018 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-11 | 0000950170-25-037335 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsForeign | Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent | pure | 0.009 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-11 | 0000950170-25-037335 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | 0.03 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxSettlementsForeign | Effective Income Tax Rate Reconciliation, Tax Settlement, Foreign, Percent | pure | 0.056 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-11 | 0000950170-25-037335 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 2.66M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | USD | 5.40M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 | |
| us-gaap | EntertainmentLicenseAgreementForProgramMaterialLiabilityNoncurrent | EntertainmentLicenseAgreementForProgramMaterialLiabilityNoncurrent | USD | 775,000 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-07 | 0000950170-23-060377 | |
| us-gaap | ExtinguishmentOfDebtGainLossNetOfTax | Extinguishment of Debt, Gain (Loss), Net of Tax | USD | 0 | 2015-01-01 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-10 | 0001564590-15-010364 |
| us-gaap | FairValueAdjustmentOfWarrants | Fair Value Adjustment of Warrants | USD | 6.22M | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-13 | 0001493152-21-011221 |
| us-gaap | FairValueAssumptionsExpectedDividendRate | Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) | pure | 0 | 2014-01-01 | 2014-06-30 | 2015 | FY | 10-K | 2016-03-28 | 0001564590-16-015403 |
| us-gaap | FairValueAssumptionsExpectedVolatilityRate | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) | pure | 0.66 | 2014-01-01 | 2014-06-30 | 2015 | FY | 10-K | 2016-03-28 | 0001564590-16-015403 |
| us-gaap | FairValueAssumptionsRiskFreeInterestRate | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) | pure | 0.013 | 2014-01-01 | 2014-06-30 | 2015 | FY | 10-K | 2016-03-28 | 0001564590-16-015403 |
| us-gaap | FinanceLeaseLiabilityPaymentsDue | Finance Lease, Liability, Payment, Due | USD | 823,615 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-12 | 0000950170-24-030133 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueNextTwelveMonths | Finance Lease, Liability, to be Paid, Year One | USD | 279,585 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-12 | 0000950170-24-030133 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearFive | Finance Lease, Liability, to be Paid, Year Five | USD | 252,333 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-07 | 0000950170-23-060377 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearFour | Finance Lease, Liability, to be Paid, Year Four | USD | 291,697 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-07 | 0000950170-23-060377 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearThree | Finance Lease, Liability, to be Paid, Year Three | USD | 252,333 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-12 | 0000950170-24-030133 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearTwo | Finance Lease, Liability, to be Paid, Year Two | USD | 291,697 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-12 | 0000950170-24-030133 | |
| us-gaap | ForeignCurrencyTransactionGainLossBeforeTax | Foreign Currency Transaction Gain (Loss), before Tax | USD | 196,000 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0000950170-24-123486 |
| us-gaap | ForeignCurrencyTransactionLossBeforeTax | Foreign Currency Transaction Loss, before Tax | USD | 45,833 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-16 | 0001493152-20-004077 |
| us-gaap | FurnitureAndFixturesGross | Furniture and Fixtures, Gross | USD | 35,209 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-10 | 0001564590-15-010364 | |
| us-gaap | FutureMinimumSubleaseRentalsSaleLeasebackTransactions | Future Minimum Sublease Rentals, Sale Leaseback Transactions | USD | 1.11M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0000950170-21-004269 | |
| us-gaap | FutureMinimumSubleaseRentalsSaleLeasebackTransactionsDueInRollingAfterYearFive | Future Minimum Sublease Rentals, Sale Leaseback Transactions, Due in Rolling after Year Five | USD | 252,333 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0000950170-21-004269 | |
| us-gaap | FutureMinimumSubleaseRentalsSaleLeasebackTransactionsDueInRollingYearFive | Future Minimum Sublease Rentals, Sale Leaseback Transactions, Due in Rolling Year Five | USD | 290,688 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0000950170-21-004269 | |
| us-gaap | FutureMinimumSubleaseRentalsSaleLeasebackTransactionsDueInRollingYearFour | Future Minimum Sublease Rentals, Sale Leaseback Transactions, Due in Rolling Year Four | USD | 278,576 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0000950170-21-004269 | |
| us-gaap | FutureMinimumSubleaseRentalsSaleLeasebackTransactionsDueInRollingYearThree | Future Minimum Sublease Rentals, Sale Leaseback Transactions, Due in Rolling Year Three | USD | 185,717 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0000950170-21-004269 | |
| us-gaap | FutureMinimumSubleaseRentalsSaleLeasebackTransactionsDueInRollingYearTwo | Future Minimum Sublease Rentals, Sale Leaseback Transactions, Due in Rolling Year Two | USD | 104,971 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0000950170-21-004269 | |
| us-gaap | FutureMinimumSubleaseRentalsSaleLeasebackTransactionsNextRollingTwelveMonths | Future Minimum Sublease Rentals, Sale Leaseback Transactions, Next Rolling Twelve Months | USD | 0 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0000950170-21-004269 | |
| us-gaap | GainLossOnSaleOfDerivatives | Gain (Loss) on Sale of Derivatives | USD | 39,000 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0000950170-24-123486 |
| us-gaap | GainLossOnSaleOfInvestments | Gain (Loss) on Sale of Investments | USD | -790 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-07 | 0000950170-23-060377 |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-12 | 0000950170-24-030133 |
| us-gaap | GainLossOnSalesOfAssetsAndAssetImpairmentCharges | Gain (Loss) on Sale of Assets and Asset Impairment Charges | USD | -606,078 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-07 | 0000950170-23-006469 |
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | 145,006 | 2014-01-01 | 2014-12-31 | 2015 | FY | 10-K | 2016-03-28 | 0001564590-16-015403 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 14.08M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | GrantsReceivableCurrent | Grants Receivable, Current | USD | 1.00M | 2016-12-31 | 2017 | FY | 10-K | 2018-03-12 | 0001493152-18-003208 | |
| us-gaap | IncomeTaxCreditsAndAdjustments | Income Tax Credits and Adjustments | USD | 1.50M | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-12 | 0001193125-25-277748 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 1,877 | 2016-01-01 | 2016-09-30 | 2017 | Q3 | 10-Q | 2017-11-08 | 0001493152-17-012574 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 12.62M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -16.49M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 587,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount | USD | 21.50M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-11 | 0000950170-25-037335 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | 124,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | -2.35M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 1.75M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | 13.32M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | IncreaseDecreaseInContractWithCustomerAsset | Increase (Decrease) in Contract with Customer, Asset | USD | -212,000 | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-06 | 0000950170-24-091922 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | -3.98M | 2019-01-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-08 | 0001493152-19-011835 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | -4.73M | 2020-01-01 | 2020-06-30 | 2021 | Q2 | 10-Q | 2021-08-12 | 0001493152-21-019441 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentAssets | Increase (Decrease) in Other Noncurrent Assets | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentLiabilities | Increase (Decrease) in Other Noncurrent Liabilities | USD | 10,205 | 2016-01-01 | 2016-09-30 | 2017 | Q3 | 10-Q | 2017-11-08 | 0001493152-17-012574 |
| us-gaap | IncreaseDecreaseInOtherOperatingAssets | Increase (Decrease) in Other Operating Assets | USD | 1.47M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-12 | 0000950170-24-030133 |
| us-gaap | IncreaseDecreaseInOtherOperatingLiabilities | Increase (Decrease) in Other Operating Liabilities | USD | 7,905 | 2016-01-01 | 2016-03-31 | 2017 | Q1 | 10-Q | 2017-05-09 | 0001493152-17-004896 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 1.88M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-12 | 0001493152-18-003208 |
| us-gaap | IncreaseDecreaseInPrepaidExpense | Increase (Decrease) in Prepaid Expense | USD | 1.38M | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-07 | 0000950170-23-060377 |
| us-gaap | IncreaseDecreaseInPrepaidExpensesOther | Increase (Decrease) in Prepaid Expenses, Other | USD | 599,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | IncreaseDecreaseInReceivables | Increase (Decrease) in Receivables | USD | -5.00M | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-16 | 0001493152-20-004077 |
| us-gaap | IncreaseDecreaseInRestrictedCashForOperatingActivities | Increase (Decrease) in Restricted Cash for Operating Activities | USD | 150,000 | 2016-01-01 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-10 | 0001493152-16-014751 |
| us-gaap | InterestExpense | Interest Expense | USD | 1.49M | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-06 | 0000950170-24-091922 |
| us-gaap | InterestExpenseDebt | Interest Expense, Debt | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 |
| us-gaap | InterestExpenseLesseeAssetsUnderCapitalLease | Interest Expense, Lessee, Assets under Capital Lease | USD | 712 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-12 | 0001493152-18-003208 |
| us-gaap | InterestExpenseNonoperating | InterestExpenseNonoperating | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 |
| us-gaap | InterestIncomeExpenseNet | Interest Income (Expense), Net | USD | 2.76M | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0000950170-24-123486 |
| us-gaap | InterestIncomeExpenseNonoperatingNet | Interest Income (Expense), Nonoperating, Net | USD | 1.08M | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-07 | 0001493152-19-016601 |
| us-gaap | InterestPaid | Interest Paid, Including Capitalized Interest, Operating and Investing Activities | USD | 2,562 | 2017-01-01 | 2017-06-30 | 2017 | Q2 | 10-Q | 2017-08-09 | 0001493152-17-008712 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 |
| us-gaap | InterestPayableCurrent | Interest Payable, Current | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-11 | 0000950170-25-037335 | |
| us-gaap | InvestmentIncomeAmortizationOfPremium | Investment Income, Amortization of Premium | USD | 232,844 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0000950170-22-023282 |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 114,642 | 2020-01-01 | 2020-06-30 | 2020 | Q2 | 10-Q/A | 2020-08-31 | 0001493152-20-017022 |
| us-gaap | InvestmentIncomeNetAmortizationOfDiscountAndPremium | Investment Income, Net, Amortization of Discount and Premium | USD | 761,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | LeaseAndRentalExpense | Operating Leases, Rent Expense | USD | 587,963 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-12 | 0001493152-19-003143 |
| us-gaap | LeaseCost | Lease, Cost | USD | 1.24M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 |
| us-gaap | LeaseholdImprovementsGross | Leasehold Improvements, Gross | USD | 19,310 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-10 | 0001564590-15-010364 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 5.26M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 1.27M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 309,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 1.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 1.02M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 953,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 653,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 1.28M | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-09 | 0000950170-23-019825 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 1.35M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | LettersOfCreditOutstandingAmount | Letters of Credit Outstanding, Amount | USD | 13,728 | 2014-07-01 | 2016 | FY | 10-K | 2017-03-08 | 0001493152-17-002256 | |
| us-gaap | Liabilities | Liabilities | USD | 38.14M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 122.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | LiabilitiesAssumed1 | Liabilities Assumed | USD | 195,181 | 2020-01-01 | 2020-06-30 | 2021 | Q2 | 10-Q | 2021-08-12 | 0001493152-21-019441 |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 34.97M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | LiabilityForUncertainTaxPositionsCurrent | Liability for Uncertainty in Income Taxes, Current | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-11 | 0000950170-25-037335 | |
| us-gaap | LineOfCreditFacilityIncreaseDecreaseForPeriodNet | Line of Credit Facility, Increase (Decrease), Net | USD | 36,375 | 2016-01-01 | 2016-06-30 | 2016 | Q2 | 10-Q | 2016-08-12 | 0001493152-16-012283 |
| us-gaap | LitigationSettlementExpense | Litigation Settlement, Expense | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-12 | 0000950170-24-030133 |
| us-gaap | LoansPayable | Loans Payable | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-11 | 0000950170-25-037335 | |
| us-gaap | LongTermDebt | Long-term Debt | USD | 17.89M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-12 | 0000950170-24-030133 | |
| us-gaap | LongTermDebtCurrent | Long-term Debt, Current Maturities | USD | 12.76M | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-07 | 0000950170-24-054625 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths | Long-Term Debt, Maturity, Year One | USD | 14.56M | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-07 | 0000950170-24-054625 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour | Long-Term Debt, Maturity, Year Four | USD | 8.26M | 2020-12-31 | 2020 | FY | 10-K | 2021-03-15 | 0001493152-21-006016 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree | Long-Term Debt, Maturity, Year Three | USD | 8.26M | 2021-12-31 | 2021 | FY | 10-K | 2022-03-08 | 0000950170-22-003145 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo | Long-Term Debt, Maturity, Year Two | USD | 17.89M | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-08 | 0000950170-23-039960 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear | Long-Term Debt, Maturity, Remainder of Fiscal Year | USD | 2.13M | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-07 | 0000950170-23-060377 | |
| us-gaap | LongTermDebtNoncurrent | Long-term Debt, Excluding Current Maturities | USD | 0 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-07 | 0000950170-24-054625 | |
| us-gaap | LongTermNotesPayable | Notes Payable, Noncurrent | USD | 0 | 2016-03-31 | 2016 | Q1 | 10-Q | 2016-05-13 | 0001564590-16-019363 | |
| us-gaap | MarketableSecurities | Marketable Securities | USD | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-15 | 0001493152-21-006016 | |
| us-gaap | MarketableSecuritiesCurrent | Marketable Securities, Current | USD | 69.74M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0000950170-21-004269 | |
| us-gaap | MarketableSecuritiesUnrealizedGainLoss | Marketable Securities, Unrealized Gain (Loss) | USD | -143,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | MoneyMarketFundsAtCarryingValue | Money Market Funds, at Carrying Value | USD | 63.23M | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-13 | 0001493152-21-011221 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 27.63M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | NetCashProvidedByUsedInFinancingActivitiesContinuingOperations | Net Cash Provided by (Used in) Financing Activities, Continuing Operations | USD | 11.13M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001493152-18-006568 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 50.28M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | NetCashProvidedByUsedInInvestingActivitiesContinuingOperations | Net Cash Provided by (Used in) Investing Activities, Continuing Operations | USD | -1.27M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001493152-18-006568 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -76.44M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | Net Cash Provided by (Used in) Operating Activities, Continuing Operations | USD | -1.60M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001493152-18-006568 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -95.76M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | NetIncomeLossAttributableToNoncontrollingInterest | Net Income (Loss) Attributable to Noncontrolling Interest | USD | -78.54M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -12.43M | 2016-01-01 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-10 | 0001493152-16-014751 |
| us-gaap | NetInvestmentIncome | Net Investment Income | USD | 3.64M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 3.56M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | NotesPayable | Notes Payable | USD | 271,757 | 2016-12-31 | 2017 | Q3 | 10-Q | 2017-11-08 | 0001493152-17-012574 | |
| us-gaap | NotesPayableCurrent | Notes Payable, Current | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-11 | 0000950170-25-037335 | |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2020-01-01 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-06 | 0001493152-20-014895 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 99.32M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -99.32M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 1.24M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 1.70M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-12 | 0000950170-24-030133 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 3.91M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 732,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 3.18M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 3.53M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 724,858 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-07 | 0000950170-23-006469 |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 5.03M | 2018-12-31 | 2019 | FY | 10-K | 2020-03-16 | 0001493152-20-004077 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 623,958 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-16 | 0001493152-20-004077 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFiveYears | Operating Leases, Future Minimum Payments, Due in Five Years | USD | 879,699 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-16 | 0001493152-20-004077 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFourYears | Operating Leases, Future Minimum Payments, Due in Four Years | USD | 855,150 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-16 | 0001493152-20-004077 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 830,600 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-16 | 0001493152-20-004077 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 784,243 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-16 | 0001493152-20-004077 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueThereafter | Operating Leases, Future Minimum Payments, Due Thereafter | USD | 1.06M | 2018-12-31 | 2019 | FY | 10-K | 2020-03-16 | 0001493152-20-004077 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year | USD | 117,500 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-08 | 0001493152-18-015417 | |
| us-gaap | OperatingLeasesRentExpenseNet | Operating Leases, Rent Expense, Net | USD | 969,370 | 2017-01-01 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-09 | 0001493152-17-004896 |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.08 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 | |
| us-gaap | OperatingLossCarryforwards | Operating Loss Carryforwards | USD | 99.75M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-16 | 0001493152-20-004077 | |
| us-gaap | OperatingLossCarryforwardsValuationAllowance | Operating Loss Carryforwards, Valuation Allowance | USD | 4.57M | 2020-12-31 | 2021 | Q2 | 10-Q | 2021-08-12 | 0001493152-21-019441 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 1.74M | 2021-12-31 | 2021 | FY | 10-K | 2022-03-08 | 0000950170-22-003145 | |
| us-gaap | OtherAccruedLiabilitiesCurrentAndNoncurrent | Other Accrued Liabilities | USD | 0 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-06 | 0000950170-24-091922 | |
| us-gaap | OtherAssets | Other Assets | USD | 2.21M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-11 | 0000950170-25-037335 | |
| us-gaap | OtherComprehensiveIncomeLossNetOfTax | Other Comprehensive Income (Loss), Net of Tax | USD | -143,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent | USD | -8,967 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0000950170-21-004269 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | -143,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | OtherIncome | Other Income | USD | -100,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-11 | 0000950170-25-037335 | |
| us-gaap | OtherLongTermDebtCurrent | Other Long-term Debt, Current | USD | 12.76M | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-07 | 0000950170-24-054625 | |
| us-gaap | OtherNonoperatingIncome | Other Nonoperating Income | USD | 4.58M | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-16 | 0001493152-20-004077 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | -86,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | OtherOperatingIncomeExpenseNet | Other Operating Income (Expense), Net | USD | 3.56M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | OtherPrepaidExpenseCurrent | Other Prepaid Expense, Current | USD | 1.50M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 | |
| us-gaap | PaidInKindInterest | Paid-in-Kind Interest | USD | 29,861 | 2014-01-01 | 2014-12-31 | 2015 | FY | 10-K | 2016-03-28 | 0001564590-16-015403 |
| us-gaap | PaymentOfFinancingAndStockIssuanceCosts | Payment of Financing and Stock Issuance Costs | USD | 6.69M | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-07 | 0000950170-24-054625 |
| us-gaap | PaymentsForRent | Payments for Rent | USD | 1.80M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 6.86M | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-07 | 0000950170-24-054625 |
| us-gaap | PaymentsToAcquireInvestments | Payments to Acquire Investments | USD | 63.34M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 77.27M | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0000950170-21-004269 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 27,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | PreferredUnitsOfferingCosts | Preferred Units, Offering Costs | USD | 1.86M | 2014-12-31 | 2014 | FY | 10-K | 2015-02-10 | 0001193125-15-040326 | |
| us-gaap | PrepaidExpenseAndOtherAssets | Prepaid Expense and Other Assets | USD | 3.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 3.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 1.09M | 2021-12-31 | 2022 | Q2 | 10-Q | 2022-08-09 | 0000950170-22-016150 | |
| us-gaap | PrepaidExpenseCurrentAndNoncurrent | Prepaid Expense | USD | 1.41M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | PrepaidRent | Prepaid Rent | USD | 250,000 | 2021-08-26 | 2024 | Q1 | 10-Q | 2024-05-07 | 0000950170-24-054625 | |
| us-gaap | PrepaidTaxes | Prepaid Taxes | USD | 1.50M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 | |
| us-gaap | ProceedsFromConvertibleDebt | Proceeds from Convertible Debt | USD | 0 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-10 | 0001193125-15-040326 |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 109.00M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-12 | 0000950170-24-030133 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 27.63M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | ProceedsFromIssuanceOfDebt | Proceeds from Issuance of Debt | USD | 18.76M | 2020-01-01 | 2020-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0000950170-21-004269 |
| us-gaap | ProceedsFromIssuanceOfLongTermDebt | Proceeds from Issuance of Long-term Debt | USD | 1.38M | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-12 | 0000950170-24-030133 |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 8.40M | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-28 | 0001564590-16-015403 |
| us-gaap | ProceedsFromIssuanceOfRedeemablePreferredStock | Proceeds from Issuance of Redeemable Preferred Stock | USD | 100 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-12 | 0000950170-24-030133 |
| us-gaap | ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised | USD | 80,248 | 2017-01-01 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-09 | 0001493152-17-004896 |
| us-gaap | ProceedsFromIssuanceOfWarrants | Proceeds from Issuance of Warrants | USD | 5,000 | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-08 | 0001493152-18-015417 |
| us-gaap | ProceedsFromNotesPayable | Proceeds from Notes Payable | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-11 | 0000950170-25-037335 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 7.02M | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0000950170-21-004269 |
| us-gaap | ProceedsFromSaleMaturityAndCollectionsOfInvestments | Proceeds from Sale, Maturity and Collection of Investments | USD | 113.64M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | ProceedsFromSaleOfPropertyPlantAndEquipment | Proceeds from Sale of Property, Plant, and Equipment | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-12 | 0000950170-24-030133 |
| us-gaap | ProceedsFromShortTermDebt | Proceeds from Short-term Debt | USD | 909,375 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-15 | 0001493152-21-006016 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 337,645 | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-08 | 0001493152-18-015417 |
| us-gaap | ProceedsFromWarrantExercises | Proceeds from Warrant Exercises | USD | 1.12M | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-16 | 0001493152-20-004077 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -95.76M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | PropertyPlantAndEquipmentDisposals | Property, Plant and Equipment, Disposals | USD | 34,482 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-08 | 0001493152-17-002256 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 4.49M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 36,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | ProvisionForOtherCreditLosses | Provision for Other Credit Losses | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 |
| us-gaap | ReceivablesFromCustomers | Receivables from Customers | USD | 5.00M | 2020-06-30 | 2020 | Q2 | 10-Q/A | 2020-08-31 | 0001493152-20-017022 | |
| us-gaap | RepaymentsOfDebt | Repayments of Debt | USD | 1.50M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-07 | 0000950170-23-006469 |
| us-gaap | RepaymentsOfLongTermCapitalLeaseObligations | Repayments of Long-term Capital Lease Obligations | USD | 375 | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-15 | 0001493152-21-006016 |
| us-gaap | RepaymentsOfNotesPayable | Repayments of Notes Payable | USD | 752,659 | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-09 | 0001493152-20-020841 |
| us-gaap | RepaymentsOfOtherLongTermDebt | Repayments of Other Long-term Debt | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 |
| us-gaap | RepaymentsOfShortTermDebt | Repayments of Short-term Debt | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 85.24M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | RestrictedCash | Restricted Cash | USD | 385,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | RestrictedCashAndCashEquivalents | Restricted Cash and Cash Equivalents | USD | 158,991 | 2017-12-31 | 2018 | Q3 | 10-Q | 2018-11-08 | 0001493152-18-015417 | |
| us-gaap | RestrictedCashAndCashEquivalentsAtCarryingValue | Restricted Cash and Cash Equivalents, Current | USD | 158,991 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-12 | 0001493152-19-003143 | |
| us-gaap | RestrictedCashAndCashEquivalentsNoncurrent | Restricted Cash and Cash Equivalents, Noncurrent | USD | 50,000 | 2016-12-31 | 2017 | FY | 10-K | 2018-03-12 | 0001493152-18-003208 | |
| us-gaap | RestrictedCashCurrent | Restricted Cash, Current | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 385,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -651.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-07 | 0000950170-23-006469 |
| us-gaap | RevenueRecognitionMilestoneMethodRevenueRecognized | Revenue Recognition, Milestone Method, Revenue Recognized | USD | 12.50M | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-08 | 0001493152-18-015417 |
| us-gaap | Revenues | Revenues | USD | 1.89M | 2019-01-01 | 2019-03-31 | 2019 | Q1 | 10-Q | 2019-05-09 | 0001493152-19-006611 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 3.22M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 5.53M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | shares | 13,165 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-12 | 0000950170-24-030133 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | USD/shares | 4.44 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-12 | 0000950170-24-030133 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares | 31,076 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-12 | 0000950170-24-030133 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 4.84 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-12 | 0000950170-24-030133 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | shares | 17,911 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-12 | 0000950170-24-030133 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | USD/shares | 5.14 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-12 | 0000950170-24-030133 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | shares | 5.67M | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-08 | 0001493152-18-015417 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations | shares | 86,719 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 19.81M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-16 | 0001493152-20-004077 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 838,540 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 3.83 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-16 | 0001493152-20-004077 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 1,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | USD/shares | 26.69 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 191,886 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 1.06M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 4.2 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-07 | 0000950170-23-060377 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares | shares | 498,543 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares | shares | 29,019 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-07 | 0000950170-23-006469 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value | USD/shares | 43.06 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-07 | 0000950170-23-006469 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price | USD/shares | 29.59 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-07 | 0000950170-23-006469 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 203,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 2.17M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 26.52 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value | USD | 150,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number | shares | 401,416 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-07 | 0000950170-23-060377 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price | USD/shares | 52.13 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 17.88M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-12 | 0000950170-24-030133 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 663,007 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-12 | 0000950170-24-030133 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 67.78 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-12 | 0000950170-24-030133 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | USD | 3.60M | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-09 | 0001493152-20-020841 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | shares | 107,269 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-07 | 0000950170-23-006469 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value | USD/shares | 67.54 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-07 | 0000950170-23-006469 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 9.79 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 11.35 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 9.59 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | ShortTermInvestments | Short-term Investments | USD | 85.09M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 84.76M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 | |
| us-gaap | StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | USD | 5.86M | 2014-12-31 | 2014 | FY | 10-K | 2015-02-10 | 0001193125-15-040326 | |
| us-gaap | StockIssued1 | Stock Issued | USD | 225,501 | 2017-01-01 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-12 | 0001493152-19-003143 |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 947,454 | 2019-01-01 | 2019-03-31 | 2019 | Q1 | 10-Q | 2019-05-09 | 0001493152-19-006611 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 812 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 396,192 | 2014-01-01 | 2014-12-31 | 2015 | FY | 10-K | 2016-03-28 | 0001564590-16-015403 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfUnits | Stock Issued During Period, Value, Conversion of Units | USD | 1.11M | 2014-01-01 | 2014-12-31 | 2015 | FY | 10-K | 2016-03-28 | 0001564590-16-015403 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 27.62M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | StockIssuedDuringPeriodValueOther | Stock Issued During Period, Value, Other | USD | 5,000 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-12 | 0001493152-19-003143 |
| us-gaap | StockIssuedDuringPeriodValueShareBasedCompensation | Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | USD | 1.15M | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-28 | 0001564590-16-015403 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 8,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | SubleaseIncome | Sublease Income | USD | 0 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0000950170-21-004269 |
| us-gaap | TaxCreditCarryforwardAmount | Tax Credit Carryforward, Amount | USD | 1.76M | 2020-12-31 | 2021 | Q2 | 10-Q | 2021-08-12 | 0001493152-21-019441 | |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 22.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098530 |
| us-gaap | WeightedAverageNumberDilutedSharesOutstandingAdjustment | Weighted Average Number Diluted Shares Outstanding Adjustment | shares | 3.96M | 2019-04-01 | 2019-06-30 | 2020 | Q2 | 10-Q/A | 2020-08-31 | 0001493152-20-017022 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 19.66M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 125.25M | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-09 | 0000950170-22-016150 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 19.66M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455614 |